for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CVS ケアマーク・コーポレーション

CVS.N

現在値

72.00USD

変化

--(--)

本日のレンジ

--

 - 

--

52週レンジ

51.72

 - 

77.00

∙ 約20分前の相場を表示しています。

適時開示

CVS Health Announces Changes To Support Innovation And Growth

Feb 12 (Reuters) - CVS Health Corp <CVS.N>::CVS HEALTH ANNOUNCES CHANGES TO SUPPORT INNOVATION AND GROWTH.CVS HEALTH CORP - ALAN LOTVIN HAS BEEN APPOINTED PRESIDENT OF CVS CAREMARK.CVS HEALTH CORP - ALEC CUNNINGHAM HAS BEEN APPOINTED EXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER FOR AETNA BUSINESS.CVS HEALTH CORP - DERICA RICE, EXECUTIVE VICE PRESIDENT AND PRESIDENT, CVS CAREMARK, WILL DEPART CVS HEALTH.

Cvs Health Reports Q4 Adj Earnings Per Share Of $7.08

Feb 12 (Reuters) - CVS Health Corp <CVS.N>::CVS HEALTH REPORTS FOURTH QUARTER AND FULL-YEAR 2019 RESULTS, REFLECTING STRONG EXECUTION ACROSS THE ENTERPRISE.Q4 ADJUSTED EARNINGS PER SHARE $7.08.Q4 GAAP EARNINGS PER SHARE $1.33 FROM CONTINUING OPERATIONS.Q4 EARNINGS PER SHARE ESTIMATE $1.68 -- REFINITIV IBES DATA.SEES FY 2020 ADJUSTED EARNINGS PER SHARE $7.04 TO $7.17.SEES FY 2020 GAAP EARNINGS PER SHARE $5.47 TO $5.60 FROM CONTINUING OPERATIONS.QTRLY TOTAL REVENUES INCREASED 22.9% TO $66.9 BILLION.SEES 2020 GAAP OPERATING INCOME IN RANGE OF $12.8 BILLION TO $13.0 BILLION.SEES 2020 CASH FLOW FROM OPERATIONS IN RANGE OF $10.5 BILLION TO $11.0 BILLION.QTRLY FRONT STORE SAME STORE SALES UP 0.7%.QTRLY TOTAL SAME STORE SALES UP 3.2%.QTRLY PHARMACY SAME STORE SALES UP 4.1%.Q4 REVENUE VIEW $63.97 BILLION -- REFINITIV IBES DATA.FY2020 EARNINGS PER SHARE VIEW $7.15 -- REFINITIV IBES DATA.

CVS Health Reports Fourth Quarter And Full-Year 2019 Results

Feb 12 (Reuters) - CVS Health Corp <CVS.N>::CVS HEALTH REPORTS FOURTH QUARTER AND FULL-YEAR 2019 RESULTS, REFLECTING STRONG EXECUTION ACROSS THE ENTERPRISE.CVS HEALTH CORP - Q4 ADJUSTED EARNINGS PER SHARE $1.73 .CVS HEALTH CORP - Q4 GAAP EARNINGS PER SHARE $1.33 FROM CONTINUING OPERATIONS.CVS HEALTH CORP - Q4 EARNINGS PER SHARE ESTIMATE $1.68 -- REFINITIV IBES DATA.CVS HEALTH CORP - SEES FY 2020 ADJUSTED EARNINGS PER SHARE $7.04 TO $7.17.CVS HEALTH CORP - SEES FY 2020 GAAP EARNINGS PER SHARE $5.47 TO $5.60 FROM CONTINUING OPERATIONS.CVS HEALTH CORP - QTRLY TOTAL REVENUES INCREASED 22.9% TO $66.9 BILLION.CVS HEALTH CORP - SEES 2020 GAAP OPERATING INCOME IN RANGE OF $12.8 BILLION TO $13.0 BILLION.CVS HEALTH CORP - SEES 2020 CASH FLOW FROM OPERATIONS IN RANGE OF $10.5 BILLION TO $11.0 BILLION.CVS HEALTH CORP - QTRLY FRONT STORE SAME STORE SALES UP 0.7%.CVS HEALTH CORP - QTRLY TOTAL SAME STORE SALES UP 3.2%.CVS HEALTH CORP - QTRLY PHARMACY SAME STORE SALES UP 4.1%.CVS HEALTH CORP - Q4 REVENUE VIEW $63.97 BILLION -- REFINITIV IBES DATA.CVS HEALTH CORP - FY2020 EARNINGS PER SHARE VIEW $7.15 -- REFINITIV IBES DATA.CVS HEALTH CORP - QTRLY ADJUSTED EPS OF $1.73.

Sysco Announces Senior Leadership Changes To Accelerate Next Phase Of Development

Jan 13 (Reuters) - Sysco Corp <SYY.N>::SYSCO ANNOUNCES SENIOR LEADERSHIP CHANGES TO ACCELERATE NEXT PHASE OF DEVELOPMENT.SYSCO CORP - TOM BENÉ WILL BE STEPPING DOWN FROM HIS ROLES AS PRESIDENT AND CHIEF EXECUTIVE OFFICER EFFECTIVE JANUARY 31, 2020..SYSCO CORP - KEVIN MOST RECENTLY SERVED AS EXECUTIVE VICE PRESIDENT OF CVS HEALTH AND PRESIDENT OF CVS PHARMACY.SYSCO - BOARD HAS UNANIMOUSLY ELECTED KEVIN HOURICAN AS NEW PRESIDENT AND CHIEF EXECUTIVE OFFICER, STARTING ON FEBRUARY 1, 2020.SYSCO CORP - ELECTED LEAD INDEPENDENT DIRECTOR ED SHIRLEY AS EXECUTIVE CHAIR, REPLACING TOM BENÉ.SYSCO CORP - BRAD HALVERSON HAS BEEN ELECTED AS NEW LEAD INDEPENDENT DIRECTOR.SYSCO CORP - REMAINS CONFIDENT IN ITS ABILITY TO ACHIEVE FINANCIAL OBJECTIVES, IS ALIGNED WITH CURRENT FISCAL YEAR CONSENSUS ESTIMATES.

CVS Health Sets Quarterly Dividend Of $0.50 Per Share

Jan 2 (Reuters) - CVS Health Corp <CVS.N>::SETS QUARTERLY DIVIDEND OF $0.50 PER SHARE.

Centene And CVS Health Announce Agreement For CVS Health To Acquire Illinicare Health

Dec 2 (Reuters) - CVS Health Corp <CVS.N>::CENTENE AND CVS HEALTH ANNOUNCE AGREEMENT FOR CVS HEALTH TO ACQUIRE ILLINICARE HEALTH.CVS HEALTH CORP - TRANSACTION ENTAILS SALE OF CENTENE'S MEDICAID AND MEDICARE ADVANTAGE LINES OF BUSINESS IN ILLINOIS..CVS HEALTH CORP - CENTENE WILL RETAIN ILLINICARE'S MEDICARE-MEDICAID ALIGNMENT INITIATIVE BUSINESS.CVS HEALTH CORP - CENTENE WILL RETAIN ILLINICARE'S STATEWIDE YOUTHCARE FOSTER CARE CONTRACT.CVS HEALTH CORP - CENTENE'S AMBETTER BUSINESS IN ILLINOIS IS NOT AFFECTED BY DEAL.CVS HEALTH CORP - CENTENE AND WELLCARE CONTINUE TO EXPECT THAT CENTENE - WELLCARE TRANSACTION WILL BE COMPLETED BY FIRST HALF OF 2020.CVS HEALTH CORP - FINANCIAL TERMS OF THIS TRANSACTION WILL NOT BE DISCLOSED.CVS HEALTH CORP - TRANSACTION IMPACT TO CVS HEALTH EARNINGS ONCE CLOSED IS EXPECTED TO BE IMMATERIAL..

Activist Investor Starboard Takes Stake in CVS - WSJ

Nov 25 (Reuters) - :ACTIVIST INVESTOR STARBOARD VALUE LP HAS TAKEN A STAKE IN CVS HEALTH CORP, HELD TALKS WITH THE DRUGSTORE-AND-INSURANCE GIANT'S MANAGEMENT - WSJ.

CVS Health Says Does Not Expect Reimbursement Pressures To Abate In 2020

Nov 6 (Reuters) - CVS Health Corp <CVS.N>::CVS HEALTH CORP SAYS HEALTH CARE BENEFITS UNIT WELL POSITIONED FOR GROWTH HEADING INTO 2020: CONF. CALL.CVS HEALTH CORP SAYS MADE DECISION TO CLOSE ABOUT 75 RETAIL PHARMACY STORES DURING 2020: CONF. CALL.CVS HEALTH CORP EXPECTS ITS MEDICAL BENEFIT RATIO FOR 2019 TO BE ABOVE MIDPOINT OF ITS FORECAST RANGE OF 84%.CVS HEALTH EXECUTIVE SAYS DOES NOT EXPECT REIMBURSEMENT PRESSURES TO ABATE IN 2020.

Ups And Cvs Make First Residential Drone Deliveries Of Prescription Medicines

Nov 5 (Reuters) - CVS Health Corp <CVS.N>::UPS AND CVS MAKE FIRST RESIDENTIAL DRONE DELIVERIES OF PRESCRIPTION MEDICINES.UPS - UPS AND CVS EXPLORING A VARIETY OF DRONE DELIVERY USE CASES.UPS - UPS FLIGHT FORWARD EXPANDING DRONE DELIVERY BEYOND HOSPITAL CAMPUSES.

CVS Says Removing 22 Ounce J&J Baby Powder From Stores

Oct 24 (Reuters) - CVS Health Corp <CVS.N>::CVS SAYS CVS PHARMACY IS COMPLYING WITH JOHNSON & JOHNSON’S VOLUNTARY RECALL OF JOHNSON’S BABY POWDER 22 OZ..CVS SAYS CVS PHARMACY IS REMOVING JOHNSON’S BABY POWDER 22 OZ. PRODUCT FROM ALL STORES AND FROM CVS.COM.CVS SAYS INITIATED “DO NOT SELL” REGISTER PROMPT IN STORES TO PREVENT SALE OF JOHNSON’S BABY POWDER 22 OZ. DURING PRODUCT REMOVAL PROCESS.CVS SAYS CUSTOMERS WHO PURCHASED JOHNSON’S BABY POWDER 22 OZ. PRODUCT FROM CVS PHARMACY SHOULD DISCONTINUE USE, AND CAN RETURN IT TO CVS FOR A REFUND.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up